Literature DB >> 34981980

Brain Pathology in Multiple Sclerosis with High-Field-Strength MR Spectroscopic Imaging.

Peter B Barker1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34981980      PMCID： PMC8961717          DOI： 10.1148/radiol.212026

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  10 in total

Review 1.  Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.

Authors:  N De Stefano; M Filippi; D Miller; P J Pouwels; A Rovira; A Gass; C Enzinger; P M Matthews; D L Arnold
Journal:  Neurology       Date:  2007-11-13       Impact factor: 9.910

Review 2.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Authors:  Alan J Thompson; Brenda L Banwell; Frederik Barkhof; William M Carroll; Timothy Coetzee; Giancarlo Comi; Jorge Correale; Franz Fazekas; Massimo Filippi; Mark S Freedman; Kazuo Fujihara; Steven L Galetta; Hans Peter Hartung; Ludwig Kappos; Fred D Lublin; Ruth Ann Marrie; Aaron E Miller; David H Miller; Xavier Montalban; Ellen M Mowry; Per Soelberg Sorensen; Mar Tintoré; Anthony L Traboulsee; Maria Trojano; Bernard M J Uitdehaag; Sandra Vukusic; Emmanuelle Waubant; Brian G Weinshenker; Stephen C Reingold; Jeffrey A Cohen
Journal:  Lancet Neurol       Date:  2017-12-21       Impact factor: 44.182

3.  Value of 3T Susceptibility-Weighted Imaging in the Diagnosis of Multiple Sclerosis.

Authors:  M A Clarke; D Pareto; L Pessini-Ferreira; G Arrambide; M Alberich; F Crescenzo; S Cappelle; M Tintoré; J Sastre-Garriga; C Auger; X Montalban; N Evangelou; À Rovira
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-21       Impact factor: 3.825

4.  Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease.

Authors:  D L Arnold; P M Matthews; G Francis; J Antel
Journal:  Magn Reson Med       Date:  1990-04       Impact factor: 4.668

5.  Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis.

Authors:  Eva Heckova; Assunta Dal-Bianco; Bernhard Strasser; Gilbert J Hangel; Alexandra Lipka; Stanislav Motyka; Lukas Hingerl; Paulus S Rommer; Thomas Berger; Petra Hnilicová; Ema Kantorová; Fritz Leutmezer; Egon Kurča; Stephan Gruber; Siegfried Trattnig; Wolfgang Bogner
Journal:  Radiology       Date:  2022-01-04       Impact factor: 11.105

6.  Do All Patients with Multiple Sclerosis Benefit from the Use of Contrast on Serial Follow-Up MR Imaging? A Retrospective Analysis.

Authors:  R R Mattay; K Davtyan; M Bilello; A C Mamourian
Journal:  AJNR Am J Neuroradiol       Date:  2018-10-04       Impact factor: 3.825

Review 7.  Effective Utilization of MRI in the Diagnosis and Management of Multiple Sclerosis.

Authors:  Antonio Giorgio; Nicola De Stefano
Journal:  Neurol Clin       Date:  2018-02       Impact factor: 3.806

8.  New Prospects for Ultra-High-Field Magnetic Resonance Imaging in Multiple Sclerosis.

Authors:  Benjamin V Ineichen; Erin S Beck; Marco Piccirelli; Daniel S Reich
Journal:  Invest Radiol       Date:  2021-06-11       Impact factor: 6.016

Review 9.  2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.

Authors:  Mike P Wattjes; Olga Ciccarelli; Daniel S Reich; Brenda Banwell; Nicola de Stefano; Christian Enzinger; Franz Fazekas; Massimo Filippi; Jette Frederiksen; Claudio Gasperini; Yael Hacohen; Ludwig Kappos; David K B Li; Kshitij Mankad; Xavier Montalban; Scott D Newsome; Jiwon Oh; Jacqueline Palace; Maria A Rocca; Jaume Sastre-Garriga; Mar Tintoré; Anthony Traboulsee; Hugo Vrenken; Tarek Yousry; Frederik Barkhof; Àlex Rovira
Journal:  Lancet Neurol       Date:  2021-06-14       Impact factor: 44.182

10.  High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI.

Authors:  Gilbert Hangel; Cornelius Cadrien; Philipp Lazen; Julia Furtner; Alexandra Lipka; Eva Hečková; Lukas Hingerl; Stanislav Motyka; Stephan Gruber; Bernhard Strasser; Barbara Kiesel; Mario Mischkulnig; Matthias Preusser; Thomas Roetzer; Adelheid Wöhrer; Georg Widhalm; Karl Rössler; Siegfried Trattnig; Wolfgang Bogner
Journal:  Neuroimage Clin       Date:  2020-09-15       Impact factor: 4.881
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.